In this study, there was no significant injury to the lungs, kidney, or other important organs after the intraplastic injection of siRNA-RRM2 directly into a transplanted tumor, indicating that siRNA-RRM2 does not cause serious adverse reactions. This evidence concerns the gene RRM2 and neoplasm.